Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Magnetic Resonance Imaging Systems Market Size

ID: MRFR/MED/4735-HCR
110 Pages
Rahul Gotadki
April 2026

Magnetic Resonance Imaging (MRI) Systems Market Research Report: Size, Share, Trend Analysis By Technology (Closed MRI Systems, Open MRI Systems, Functional MRI Systems, High-Field MRI Systems), By Applications (Oncology, Neurology, Cardiology, Musculoskeletal Imaging, Gastrointestinal Imaging), By End Use (Hospitals, Diagnostic Imaging Centers, Research Institutes, Ambulatory Surgical Centers), By Field Strength (Low-Field MRI Systems, Mid-Field MRI Systems, High-Field MRI Systems) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Magnetic Resonance Imaging Systems Market Infographic
Purchase Options

Magnetic Resonance Imaging Systems Size

Magnetic Resonance Imaging Systems Market Growth Projections and Opportunities

Fast mechanical headways considerably affect the market for magnetic resonance imaging systems frameworks. Progressing headways in imaging innovation, including the execution of additional strong attractive fields and refined imaging successions, animate market extension through the arrangement of improved demonstrative functionalities and predominant picture quality. The raising pervasiveness of constant sicknesses, like cardiovascular circumstances, neurological issues, and malignant growth, significantly expands the requirement for magnetic resonance imaging systems frameworks. Because of the way that these circumstances require definite and exact imaging for precise analysis and treatment arranging, the extending patient populace invigorates the market. The developing extent of the total populace is maturing, which has prompted a flood in the requirement for magnetic resonance imaging systems. The old habitually require thorough clinical assessments, delivering attractive magnetic resonance imaging systems a vital instrument in the recognizable proof old enough related unexpected issues. This segment shift is a critical figure for the development of the market. Medical care ventures and government drives that mean to work on the framework and availability of medical care are huge variables impacting the magnetic resonance imaging systems market. The multiplication of medical services framework, explicitly in creating regions, is worked with by expanded monetary interests in imaging innovation. The interest in magnetic resonance imaging systems is impelled by the rising awareness among patients concerning the upsides of early sickness location and their inclination for painless symptomatic techniques. There is a developing pattern among patients to incline toward imaging modalities that give thorough information without requiring intrusive methodology, which solidifies the place of X-ray as the ideal choice. The joining of computerized reasoning (artificial intelligence) into attractive reverberation imaging (X-ray) frameworks has achieved a huge change in outlook in the fields of picture examination and translation. Computerized reasoning calculations work on the proficiency and accuracy of conclusion processes by supporting the ID of abnormalities and examples that might be challenging for people to freely decipher. The coordination being referred to upgrades market development through the arrangement of analytic arrangements that are more trustworthy and productive. Repayment Arrangements: The impact of repayment strategy accessibility and design on the reception of X-ray frameworks is significant. The market extends because of medical care suppliers being boosted to put resources into refined imaging advancements by positive repayment arrangements. Alternately, repayment that is confined or dubious may block market extension. Worldwide monetary variables apply an effect on the buying force of medical services establishments and in this manner influence the magnetic resonance imaging systems all in all. Interests in magnetic resonance imaging systems are supported by financial strength, though monetary requirements coming about because of monetary slumps can affect market elements.

Magnetic Resonance Imaging Systems Market Size Graph
Author
Author Profile
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Leave a Comment

FAQs

What is the projected market valuation of the Magnetic Resonance Imaging Systems Market by 2035?

<p>The projected market valuation for the Magnetic Resonance Imaging Systems Market is 13.55 USD Billion by 2035.</p>

What was the market valuation of the Magnetic Resonance Imaging Systems Market in 2024?

<p>The overall market valuation was 7.61 USD Billion in 2024.</p>

What is the expected CAGR for the Magnetic Resonance Imaging Systems Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Magnetic Resonance Imaging Systems Market during the forecast period 2025 - 2035 is 5.35%.</p>

Which companies are considered key players in the Magnetic Resonance Imaging Systems Market?

<p>Key players in the market include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems.</p>

What are the projected valuations for the Diagnostic Imaging segment by 2035?

<p>The projected valuation for the Diagnostic Imaging segment is expected to reach 4.5 USD Billion by 2035.</p>

How does the market for High Field MRI Systems compare to other field strengths by 2035?

<p>By 2035, the market for High Field MRI Systems is projected to reach 5.05 USD Billion, indicating strong demand.</p>

What is the expected growth for the Outpatient Facilities segment by 2035?

<p>The Outpatient Facilities segment is projected to grow to 3.7 USD Billion by 2035.</p>

What is the anticipated valuation for Superconducting MRI Systems by 2035?

<p>The anticipated valuation for Superconducting MRI Systems is expected to reach 7.56 USD Billion by 2035.</p>

What are the projected figures for Closed MRI Systems by 2035?

<p>The projected valuation for Closed MRI Systems is expected to be 6.0 USD Billion by 2035.</p>

How does the market for Functional Imaging compare to other applications by 2035?

<p>The market for Functional Imaging is projected to reach 2.5 USD Billion by 2035, reflecting its growing importance.</p>

Market Summary

As per MRFR analysis, the Magnetic Resonance Imaging Systems Market Size was estimated at 7.61 USD Billion in 2024. The Magnetic Resonance Imaging Systems industry is projected to grow from 8.1 in 2025 to 13.55 by 2035, exhibiting a compound annual growth rate (CAGR) of 5.35% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Magnetic Resonance Imaging Systems Market is poised for substantial growth driven by technological advancements and increasing healthcare demands.

  • Technological advancements in MRI systems are enhancing imaging quality and diagnostic capabilities. The market is witnessing a shift towards portable MRI solutions, catering to diverse healthcare settings. Cost-effectiveness is becoming a focal point as healthcare providers seek to optimize expenditures while maintaining quality care. The increasing prevalence of chronic diseases and the rising demand for early diagnosis are key drivers propelling market expansion, particularly in North America and the Asia-Pacific region.

Market Size & Forecast

2024 Market Size 7.61 (USD Billion)
2035 Market Size 13.55 (USD Billion)
CAGR (2025 - 2035) 5.35%
Largest Regional Market Share in 2024 North America

Major Players

Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Hitachi Medical Systems (JP), Fujifilm Medical Systems (JP), Bruker Corporation (US), Esaote S.p.A. (IT), Mindray Medical International Limited (CN)

Market Trends

The Magnetic Resonance Imaging Systems Market is currently experiencing a transformative phase, characterized by advancements in technology and increasing demand for non-invasive diagnostic tools. The integration of artificial intelligence and machine learning into imaging systems is enhancing the accuracy and efficiency of diagnoses, thereby improving patient outcomes. Furthermore, the growing prevalence of chronic diseases necessitates the adoption of advanced imaging modalities, as healthcare providers seek to offer precise and timely interventions. This trend is further supported by an expanding geriatric population, which is more susceptible to conditions requiring detailed imaging assessments. In addition to technological innovations, the Magnetic Resonance Imaging Systems Market is witnessing a shift towards portable and compact imaging solutions. These systems are designed to facilitate accessibility in various healthcare settings, including remote and underserved areas. The emphasis on cost-effective solutions is also driving the development of budget-friendly MRI systems, which could potentially democratize access to high-quality imaging services. As the market evolves, stakeholders must remain vigilant to emerging trends and adapt their strategies accordingly to maintain competitiveness in this dynamic landscape.

Technological Advancements

The integration of cutting-edge technologies, such as artificial intelligence and machine learning, is revolutionizing the Magnetic Resonance Imaging Systems Market. These innovations enhance diagnostic accuracy and operational efficiency, leading to improved patient care.

Shift Towards Portable Solutions

There is a noticeable trend towards the development of portable Magnetic Resonance Imaging Systems. These compact devices aim to increase accessibility in diverse healthcare environments, particularly in remote or underserved regions.

Focus on Cost-Effectiveness

The market is increasingly prioritizing cost-effective MRI solutions. This focus on affordability may facilitate broader access to advanced imaging technologies, enabling more healthcare facilities to offer high-quality diagnostic services.

Magnetic Resonance Imaging Systems Market Market Drivers

Market Growth Projections

The Global Magnetic Resonance Imaging (MRI) Systems Market Industry is projected to experience substantial growth over the coming years. The market is expected to reach a valuation of 12 USD Billion by 2035, driven by various factors including technological advancements, rising healthcare expenditure, and an increasing geriatric population. The compound annual growth rate (CAGR) is anticipated to be 4.43% from 2025 to 2035, indicating a robust demand for MRI systems. This growth trajectory suggests a favorable environment for manufacturers and healthcare providers alike, as they adapt to evolving market dynamics and consumer needs.

Growing Geriatric Population

The Global Magnetic Resonance Imaging (MRI) Systems Market Industry is also driven by the growing geriatric population, which is more susceptible to various health conditions requiring advanced imaging techniques. As the global population ages, the demand for MRI systems is likely to rise, as older adults often require more frequent diagnostic imaging. This demographic shift is expected to propel the market forward, with a projected compound annual growth rate (CAGR) of 4.43% from 2025 to 2035. Healthcare facilities are adapting to this trend by upgrading their imaging equipment to meet the needs of an aging population.

Increased Healthcare Expenditure

The Global Magnetic Resonance Imaging (MRI) Systems Market Industry is benefiting from increased healthcare expenditure across various regions. Governments and private sectors are investing more in healthcare infrastructure, which includes the acquisition of advanced imaging technologies. This trend is particularly evident in emerging economies, where healthcare reforms are leading to enhanced access to diagnostic services. As a result, the demand for MRI systems is expected to grow, contributing to a market valuation of 12 USD Billion by 2035. Enhanced funding for healthcare initiatives is likely to facilitate the adoption of MRI technology in hospitals and clinics.

Rising Awareness of Early Diagnosis

The Global Magnetic Resonance Imaging (MRI) Systems Market Industry is witnessing growth due to rising awareness of the importance of early diagnosis in improving health outcomes. Patients and healthcare providers are increasingly recognizing the value of MRI in detecting diseases at earlier stages, which can lead to more effective treatment options. This heightened awareness is driving demand for MRI systems, as healthcare facilities strive to offer comprehensive diagnostic services. With the market projected to reach 7.45 USD Billion in 2024, the emphasis on early diagnosis is likely to play a crucial role in shaping the future of MRI technology.

Rising Prevalence of Chronic Diseases

The Global Magnetic Resonance Imaging (MRI) Systems Market Industry is significantly influenced by the rising prevalence of chronic diseases such as cancer, neurological disorders, and cardiovascular diseases. As these conditions become more common, the demand for advanced diagnostic imaging solutions increases. MRI is particularly valued for its non-invasive nature and ability to provide detailed images of soft tissues. This trend is expected to contribute to the market's growth, with projections indicating a market value of 12 USD Billion by 2035. Healthcare providers are increasingly investing in MRI technology to enhance diagnostic capabilities and improve patient care.

Technological Advancements in MRI Systems

The Global Magnetic Resonance Imaging (MRI) Systems Market Industry is experiencing rapid technological advancements, which are enhancing imaging capabilities and patient outcomes. Innovations such as functional MRI and high-field MRI systems are becoming increasingly prevalent. These advancements allow for improved diagnostic accuracy and faster imaging times, which are critical in clinical settings. As of 2024, the market is valued at approximately 7.45 USD Billion, reflecting the growing demand for advanced imaging technologies. The integration of artificial intelligence in MRI systems is also anticipated to streamline workflows and reduce operational costs, further driving market growth.

Market Segment Insights

By Application: Diagnostic Imaging (Largest) vs. Functional Imaging (Fastest-Growing)

The Magnetic Resonance Imaging Systems Market is predominantly driven by the diagnostic imaging segment, which leads with the largest market share due to its widespread application in clinical practice. Diagnostic imaging is fundamental for disease detection and monitoring, positioning itself as the backbone of MRI usage in hospitals and diagnostic centers. Functional imaging, on the other hand, is emerging as the fastest-growing segment, leveraging advancements in technology to offer more detailed insights into physiological functions, further expanding its adoption in research and clinical settings.

Functional Imaging (Dominant) vs. Cardiac Imaging (Emerging)

Functional imaging holds a significant position in the Magnetic Resonance Imaging Systems Market as it enables the visualization of dynamic processes in the body, such as blood flow and neural activity. This segment leverages cutting-edge technologies to provide critical insights for conditions such as epilepsy and brain tumors, making it a vital tool in neurology. In contrast, cardiac imaging is recognized as an emerging segment, focusing on the assessment of heart conditions and aiding in the diagnosis of cardiovascular diseases. While it is not as established as functional imaging, ongoing innovations in imaging technology and increasing prevalence of heart-related ailments are driving its growth, suggesting a promising future.

By End Use: Hospitals (Largest) vs. Diagnostic Imaging Centers (Fastest-Growing)

In the Magnetic Resonance Imaging Systems Market, hospitals dominate the landscape, accounting for a substantial share of the end-use segment. This is primarily due to their comprehensive array of services, combining both diagnostics and treatment options. As centers offering significant patient volumes, hospitals continue to invest in advanced MRI systems to enhance their capabilities and patient care. In contrast, diagnostic imaging centers are emerging strongly in the market, capitalizing on the trend towards specialized diagnostics and outpatient services. As healthcare systems focus on efficiency and patient-centered care, these centers are positioned for significant growth, driven by technology advancements and increased demand for imaging services. The growth trends in this segment are largely influenced by technological innovations, the increasing prevalence of chronic diseases, and an aging population requiring additional diagnostic services. Diagnostic imaging centers are benefiting from the shift towards outpatient care, making them agile and more attractive to patients seeking faster and more specialized services. Moreover, advancements in MRI technology are creating new opportunities for rapid diagnosis, significantly enhancing operational efficiency. In addition, the growing collaboration between hospitals and imaging centers is facilitating a broader reach for MRIs, contributing to the market's expansion overall.

Hospitals (Dominant) vs. Research Institutions (Emerging)

Hospitals are by far the dominant players in the Magnetic Resonance Imaging Systems Market due to their extensive investments in healthcare infrastructure and technology. They provide comprehensive medical services and are equipped to handle complex diagnostic needs. With established protocols and a broad patient base, hospitals are leveraging state-of-the-art MRI systems to deliver accurate diagnoses and improve patient outcomes. On the other hand, research institutions are seen as emerging players in this landscape. They contribute significantly to the advancement of MRI technology and its applications in clinical research. While they may not operate at the same scale as hospitals, research institutions are crucial for pioneering new imaging methodologies and protocols, often collaborating with hospitals to translate innovations into practical applications that benefit patient care.

By Field Strength: High Field (Largest) vs. Ultra High Field (Fastest-Growing)

The Magnetic Resonance Imaging (MRI) Systems Market exhibits a diverse range of field strengths, with High Field MRIs commanding the largest market share. This segment is favored in clinical settings due to its superior image quality and resolution, making it the go-to choice for diagnostic accuracy. Meanwhile, Low Field and Mid Field segments serve niche applications, often in regions with budget constraints or specific operational requirements. These segments represent a smaller portion of the overall market, together accounting for a notable but limited share of the MRI landscape.

High Field: Dominant vs. Ultra High Field: Emerging

High Field MRI systems, typically defined as those operating in the 1.5T to 3.0T range, are characterized by their high signal-to-noise ratio, enabling detailed imaging that is crucial for accurate diagnostics. The dominant position of this segment is attributed to its widespread adoption in hospitals and imaging centers, where demand for high-resolution imaging is paramount. Conversely, Ultra High Field MRI systems, operating above 3.0T, are emerging rapidly due to advancements in technology. These systems promise enhanced imaging capabilities and offer researchers new opportunities in various medical fields, generating increasing interest from both medical professionals and institutions as they seek to improve diagnostic effectiveness and patient care.

By Technology: Closed MRI Systems (Largest) vs. Open MRI Systems (Fastest-Growing)

The Magnetic Resonance Imaging Systems Market is significantly segmented into Closed MRI Systems, Open MRI Systems, and Extremity MRI Systems, each with distinct share distributions. Closed MRI Systems dominate the market due to their superior image resolution and widespread acceptance in clinical settings. Open MRI Systems, while holding a smaller portion of the market share, are rapidly gaining traction among patients who prefer a more comfortable, less claustrophobic experience, making them a considerable competitor. Extremity MRI Systems are also present in the market, offering alternative imaging solutions but remain less adopted compared to their counterparts.

Technology: Closed MRI Systems (Dominant) vs. Open MRI Systems (Emerging)

Closed MRI Systems offer unparalleled imaging quality and are the preferred choice for diagnostic accuracy in complex medical cases, thus establishing their dominant position in the market. Their robust design allows for high field strength, providing detailed images that facilitate precise diagnoses. Conversely, Open MRI Systems have emerged as a favorable alternative, especially for patients who experience anxiety in traditional closed systems. These systems enhance patient comfort and accessibility, catering to a segment seeking less intimidating imaging experiences. The growing preference for patient-centric solutions underscores the potential of Open MRI Systems to capture a larger market share moving forward.

By Type: Superconducting MRI Systems (Largest) vs. Permanent Magnet MRI Systems (Fastest-Growing)

<p>In the Magnetic Resonance Imaging Systems Market, Superconducting MRI Systems dominate the landscape, accounting for the largest share among the various types available. Their advanced technology and excellent imaging capabilities make them the preferred choice in hospitals and clinics. Following closely are Permanent Magnet MRI Systems, which are gaining momentum as they offer cost-effective solutions with adequate imaging quality, making them attractive for smaller medical facilities and outpatient centers. Resistive MRI Systems have a smaller share of the market due to their limited performance and higher operational costs, positioning them as less favorable in comparison.</p>

<p>Technology: Superconducting MRI Systems (Dominant) vs. Permanent Magnet MRI Systems (Emerging)</p>

<p>Superconducting MRI Systems utilize advanced superconducting materials to achieve high magnetic fields, yielding superior imaging quality and faster scan times, which make them essential in large hospitals and specialized imaging centers. The robustness and reliability of these systems bolster their dominance in the market, driven by ongoing innovations and improvements. In contrast, Permanent Magnet MRI Systems are emerging rapidly, tailored for smaller imaging facilities where budget constraints are significant. Their operational efficiency, simpler design, and lower maintenance costs contribute to their appeal. While not offering the same imaging quality as superconducting systems, their ability to provide decent images makes them a viable alternative, especially where space and operational budgets are limited.</p>

Get more detailed insights about Magnetic Resonance Imaging (MRI) Systems Market Research Report – Forecast to 2035

Regional Insights

North America : Market Leader in MRI Systems

North America continues to lead the Magnetic Resonance Imaging (MRI) Systems market, holding a significant share of 3.8 billion in 2024. The growth is driven by advanced healthcare infrastructure, increasing prevalence of chronic diseases, and rising demand for non-invasive diagnostic techniques. Regulatory support and technological advancements further catalyze market expansion, ensuring that North America remains at the forefront of MRI innovation. The competitive landscape is characterized by major players such as GE Healthcare and Siemens Healthineers, which dominate the market with their cutting-edge technologies and extensive product portfolios. The U.S. is the primary contributor, supported by a robust healthcare system and significant investments in medical imaging technologies. This region's focus on research and development ensures continuous improvement and adaptation to emerging healthcare needs.

Europe : Emerging Market with Growth Potential

Europe's Magnetic Resonance Imaging Systems market is valued at 2.2 billion, reflecting a growing demand for advanced imaging solutions. Key growth drivers include an aging population, increasing healthcare expenditure, and a shift towards preventive healthcare. Regulatory frameworks in the EU promote innovation and ensure high standards in medical imaging, further enhancing market growth prospects. Leading countries such as Germany, France, and the UK are pivotal in this market, hosting major players like Philips Healthcare and Siemens Healthineers. The competitive landscape is marked by collaborations and partnerships aimed at enhancing technological capabilities. The European market is poised for growth as healthcare providers increasingly adopt MRI systems for accurate diagnostics and treatment planning.

Asia-Pacific : Rapidly Growing Healthcare Sector

The Asia-Pacific region, with a market size of 1.4 billion, is witnessing rapid growth in the Magnetic Resonance Imaging Systems sector. Factors such as rising disposable incomes, increasing healthcare access, and a growing emphasis on early disease detection are driving demand. Government initiatives aimed at improving healthcare infrastructure and technology adoption are also significant catalysts for market growth in this region. Countries like China, Japan, and India are leading the charge, with substantial investments in healthcare technology. Key players such as Canon Medical Systems and Hitachi Medical Systems are expanding their presence to meet the rising demand. The competitive landscape is evolving, with local manufacturers also entering the market, enhancing competition and innovation in MRI technologies.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa region, valued at 0.21 billion, is in the early stages of developing its Magnetic Resonance Imaging Systems market. Key growth drivers include increasing healthcare investments, a rising prevalence of chronic diseases, and a growing focus on improving diagnostic capabilities. However, challenges such as limited healthcare infrastructure and high costs of MRI systems hinder rapid market expansion. Countries like South Africa and the UAE are making strides in enhancing their healthcare systems, with investments in medical imaging technologies. The presence of key players is gradually increasing, as companies recognize the potential for growth in this region. Collaborative efforts between governments and private sectors are essential to overcome existing challenges and foster market development.

Key Players and Competitive Insights

The Magnetic Resonance Imaging Systems Market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for non-invasive diagnostic tools. Key players such as Siemens Healthineers (Germany), GE Healthcare (US), and Philips Healthcare (Netherlands) are at the forefront, each adopting distinct strategies to enhance their market presence. Siemens Healthineers (Germany) emphasizes innovation through the development of advanced imaging technologies, while GE Healthcare (US) focuses on strategic partnerships to expand its product offerings. Philips Healthcare (Netherlands) is actively pursuing digital transformation initiatives, integrating AI capabilities into its imaging systems, which collectively shapes a competitive environment that prioritizes technological superiority and customer-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Canon Medical Systems (Japan) and Hitachi Medical Systems (Japan) contributes to a competitive atmosphere where innovation and operational excellence are paramount.
In November Siemens Healthineers (Germany) announced the launch of its latest MRI system, which incorporates AI-driven analytics to improve diagnostic accuracy. This strategic move not only reinforces Siemens' commitment to innovation but also positions the company to capture a larger share of the growing demand for advanced imaging solutions. The integration of AI into MRI technology is likely to enhance workflow efficiency and patient outcomes, thereby solidifying Siemens' competitive edge.
In October GE Healthcare (US) entered a strategic partnership with a leading telehealth provider to enhance remote diagnostic capabilities. This collaboration is significant as it aligns with the increasing trend towards telemedicine, allowing GE Healthcare to expand its reach and offer integrated solutions that cater to the evolving needs of healthcare providers. Such partnerships are indicative of a broader shift towards holistic healthcare solutions, where imaging plays a crucial role in patient management.
In September Philips Healthcare (Netherlands) unveiled a new sustainability initiative aimed at reducing the environmental impact of its MRI systems. This initiative includes the development of energy-efficient machines and a commitment to sustainable manufacturing practices. As environmental concerns gain prominence, Philips' proactive approach may enhance its brand reputation and appeal to environmentally conscious healthcare institutions, thereby influencing purchasing decisions.
As of December the competitive trends in the Magnetic Resonance Imaging Systems Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, enabling companies to leverage complementary strengths and enhance their market offerings. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive advantage in a rapidly changing market.

Key Companies in the Magnetic Resonance Imaging Systems Market include

Industry Developments

Recent developments in the Global Magnetic Resonance Imaging (MRI) Systems Market have shown a notable increase in technological advancements and consolidation activities among key players. AgfaGevaert, Fujifilm Holdings Corporation, and Siemens Healthineers have all been focusing on enhancing imaging techniques and investing in Artificial Intelligence capabilities to improve diagnostic precision.

In terms of mergers and acquisitions, notable activity includes Samsung Medison's acquisition of a smaller imaging company in July 2022 to expand their technology portfolio, and GE Healthcare's partnership with local entities in markets like Asia to enhance their distribution channels as of August 2023.

As a result of these strategic moves, the market has witnessed significant growth; the valuation of the Global MRI Systems Market is projected to reach approximately USD 9.5 billion by 2024, driven largely by increasing demand for non-invasive diagnostic tools.

Additionally, the last couple of years have seen significant regulatory push towards streamlining MRI technology approval processes, aimed at accelerating the entry of innovative solutions into the market. Investments in R&D remain critical, as major players like Philips Healthcare and Mindray are committed to advancing MRI capabilities to address rising healthcare needs globally.

Future Outlook

Magnetic Resonance Imaging Systems Market Future Outlook

The Magnetic Resonance Imaging Systems Market is projected to grow at a 5.35% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare expenditure, and rising demand for diagnostic imaging.

New opportunities lie in:

  • <p>Development of portable MRI systems for remote diagnostics. Integration of AI for enhanced imaging analysis and workflow efficiency. Expansion into emerging markets with tailored financing solutions.</p>

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological innovations.

Market Segmentation

Magnetic Resonance Imaging Systems Market Type Outlook

  • Conventional MRI Systems
  • Functional MRI Systems
  • Cardiac MRI Systems

Magnetic Resonance Imaging Systems Market End Use Outlook

  • Hospitals
  • Diagnostic Imaging Centers
  • Research Institutions
  • Outpatient Facilities

Magnetic Resonance Imaging Systems Market Technology Outlook

  • Closed MRI Systems
  • Open MRI Systems
  • Extremity MRI Systems

Magnetic Resonance Imaging Systems Market Application Outlook

  • Diagnostic Imaging
  • Functional Imaging
  • Spectroscopy
  • Cardiac Imaging

Magnetic Resonance Imaging Systems Market Field Strength Outlook

  • Low Field
  • Mid Field
  • High Field
  • Ultra High Field

Report Scope

MARKET SIZE 2024 7.61(USD Billion)
MARKET SIZE 2025 8.1(USD Billion)
MARKET SIZE 2035 13.55(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.35% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Hitachi Medical Systems (JP), Fujifilm Medical Systems (JP), Bruker Corporation (US), Esaote S.p.A. (IT), Mindray Medical International Limited (CN)
Segments Covered Application, End Use, Field Strength, Technology, Type
Key Market Opportunities Integration of artificial intelligence in Magnetic Resonance Imaging Systems enhances diagnostic accuracy and operational efficiency.
Key Market Dynamics Technological advancements and regulatory changes drive competitive dynamics in the Magnetic Resonance Imaging Systems market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Magnetic Resonance Imaging Systems Market by 2035?

<p>The projected market valuation for the Magnetic Resonance Imaging Systems Market is 13.55 USD Billion by 2035.</p>

What was the market valuation of the Magnetic Resonance Imaging Systems Market in 2024?

<p>The overall market valuation was 7.61 USD Billion in 2024.</p>

What is the expected CAGR for the Magnetic Resonance Imaging Systems Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Magnetic Resonance Imaging Systems Market during the forecast period 2025 - 2035 is 5.35%.</p>

Which companies are considered key players in the Magnetic Resonance Imaging Systems Market?

<p>Key players in the market include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems.</p>

What are the projected valuations for the Diagnostic Imaging segment by 2035?

<p>The projected valuation for the Diagnostic Imaging segment is expected to reach 4.5 USD Billion by 2035.</p>

How does the market for High Field MRI Systems compare to other field strengths by 2035?

<p>By 2035, the market for High Field MRI Systems is projected to reach 5.05 USD Billion, indicating strong demand.</p>

What is the expected growth for the Outpatient Facilities segment by 2035?

<p>The Outpatient Facilities segment is projected to grow to 3.7 USD Billion by 2035.</p>

What is the anticipated valuation for Superconducting MRI Systems by 2035?

<p>The anticipated valuation for Superconducting MRI Systems is expected to reach 7.56 USD Billion by 2035.</p>

What are the projected figures for Closed MRI Systems by 2035?

<p>The projected valuation for Closed MRI Systems is expected to be 6.0 USD Billion by 2035.</p>

How does the market for Functional Imaging compare to other applications by 2035?

<p>The market for Functional Imaging is projected to reach 2.5 USD Billion by 2035, reflecting its growing importance.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Application (USD Billion)
    2. | | 4.1.1 Diagnostic Imaging
    3. | | 4.1.2 Functional Imaging
    4. | | 4.1.3 Spectroscopy
    5. | | 4.1.4 Cardiac Imaging
    6. | 4.2 Healthcare, BY End Use (USD Billion)
    7. | | 4.2.1 Hospitals
    8. | | 4.2.2 Diagnostic Imaging Centers
    9. | | 4.2.3 Research Institutions
    10. | | 4.2.4 Outpatient Facilities
    11. | 4.3 Healthcare, BY Field Strength (USD Billion)
    12. | | 4.3.1 Low Field
    13. | | 4.3.2 Mid Field
    14. | | 4.3.3 High Field
    15. | | 4.3.4 Ultra High Field
    16. | 4.4 Healthcare, BY Technology (USD Billion)
    17. | | 4.4.1 Closed MRI Systems
    18. | | 4.4.2 Open MRI Systems
    19. | | 4.4.3 Extremity MRI Systems
    20. | | 4.4.4 Hybrid MRI Systems
    21. | 4.5 Healthcare, BY Type (USD Billion)
    22. | | 4.5.1 Permanent Magnet MRI Systems
    23. | | 4.5.2 Superconducting MRI Systems
    24. | | 4.5.3 Resistive MRI Systems
    25. | 4.6 Healthcare, BY Region (USD Billion)
    26. | | 4.6.1 North America
    27. | | | 4.6.1.1 US
    28. | | | 4.6.1.2 Canada
    29. | | 4.6.2 Europe
    30. | | | 4.6.2.1 Germany
    31. | | | 4.6.2.2 UK
    32. | | | 4.6.2.3 France
    33. | | | 4.6.2.4 Russia
    34. | | | 4.6.2.5 Italy
    35. | | | 4.6.2.6 Spain
    36. | | | 4.6.2.7 Rest of Europe
    37. | | 4.6.3 APAC
    38. | | | 4.6.3.1 China
    39. | | | 4.6.3.2 India
    40. | | | 4.6.3.3 Japan
    41. | | | 4.6.3.4 South Korea
    42. | | | 4.6.3.5 Malaysia
    43. | | | 4.6.3.6 Thailand
    44. | | | 4.6.3.7 Indonesia
    45. | | | 4.6.3.8 Rest of APAC
    46. | | 4.6.4 South America
    47. | | | 4.6.4.1 Brazil
    48. | | | 4.6.4.2 Mexico
    49. | | | 4.6.4.3 Argentina
    50. | | | 4.6.4.4 Rest of South America
    51. | | 4.6.5 MEA
    52. | | | 4.6.5.1 GCC Countries
    53. | | | 4.6.5.2 South Africa
    54. | | | 4.6.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Siemens Healthineers (DE)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 GE Healthcare (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Philips Healthcare (NL)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Canon Medical Systems (JP)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Hitachi Medical Systems (JP)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Fujifilm Medical Systems (JP)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Bruker Corporation (US)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Esaote S.p.A. (IT)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 Mindray Medical International Limited (CN)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY APPLICATION
    4. | 6.4 US MARKET ANALYSIS BY END USE
    5. | 6.5 US MARKET ANALYSIS BY FIELD STRENGTH
    6. | 6.6 US MARKET ANALYSIS BY TECHNOLOGY
    7. | 6.7 US MARKET ANALYSIS BY TYPE
    8. | 6.8 CANADA MARKET ANALYSIS BY APPLICATION
    9. | 6.9 CANADA MARKET ANALYSIS BY END USE
    10. | 6.10 CANADA MARKET ANALYSIS BY FIELD STRENGTH
    11. | 6.11 CANADA MARKET ANALYSIS BY TECHNOLOGY
    12. | 6.12 CANADA MARKET ANALYSIS BY TYPE
    13. | 6.13 EUROPE MARKET ANALYSIS
    14. | 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
    15. | 6.15 GERMANY MARKET ANALYSIS BY END USE
    16. | 6.16 GERMANY MARKET ANALYSIS BY FIELD STRENGTH
    17. | 6.17 GERMANY MARKET ANALYSIS BY TECHNOLOGY
    18. | 6.18 GERMANY MARKET ANALYSIS BY TYPE
    19. | 6.19 UK MARKET ANALYSIS BY APPLICATION
    20. | 6.20 UK MARKET ANALYSIS BY END USE
    21. | 6.21 UK MARKET ANALYSIS BY FIELD STRENGTH
    22. | 6.22 UK MARKET ANALYSIS BY TECHNOLOGY
    23. | 6.23 UK MARKET ANALYSIS BY TYPE
    24. | 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
    25. | 6.25 FRANCE MARKET ANALYSIS BY END USE
    26. | 6.26 FRANCE MARKET ANALYSIS BY FIELD STRENGTH
    27. | 6.27 FRANCE MARKET ANALYSIS BY TECHNOLOGY
    28. | 6.28 FRANCE MARKET ANALYSIS BY TYPE
    29. | 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
    30. | 6.30 RUSSIA MARKET ANALYSIS BY END USE
    31. | 6.31 RUSSIA MARKET ANALYSIS BY FIELD STRENGTH
    32. | 6.32 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
    33. | 6.33 RUSSIA MARKET ANALYSIS BY TYPE
    34. | 6.34 ITALY MARKET ANALYSIS BY APPLICATION
    35. | 6.35 ITALY MARKET ANALYSIS BY END USE
    36. | 6.36 ITALY MARKET ANALYSIS BY FIELD STRENGTH
    37. | 6.37 ITALY MARKET ANALYSIS BY TECHNOLOGY
    38. | 6.38 ITALY MARKET ANALYSIS BY TYPE
    39. | 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
    40. | 6.40 SPAIN MARKET ANALYSIS BY END USE
    41. | 6.41 SPAIN MARKET ANALYSIS BY FIELD STRENGTH
    42. | 6.42 SPAIN MARKET ANALYSIS BY TECHNOLOGY
    43. | 6.43 SPAIN MARKET ANALYSIS BY TYPE
    44. | 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    45. | 6.45 REST OF EUROPE MARKET ANALYSIS BY END USE
    46. | 6.46 REST OF EUROPE MARKET ANALYSIS BY FIELD STRENGTH
    47. | 6.47 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
    48. | 6.48 REST OF EUROPE MARKET ANALYSIS BY TYPE
    49. | 6.49 APAC MARKET ANALYSIS
    50. | 6.50 CHINA MARKET ANALYSIS BY APPLICATION
    51. | 6.51 CHINA MARKET ANALYSIS BY END USE
    52. | 6.52 CHINA MARKET ANALYSIS BY FIELD STRENGTH
    53. | 6.53 CHINA MARKET ANALYSIS BY TECHNOLOGY
    54. | 6.54 CHINA MARKET ANALYSIS BY TYPE
    55. | 6.55 INDIA MARKET ANALYSIS BY APPLICATION
    56. | 6.56 INDIA MARKET ANALYSIS BY END USE
    57. | 6.57 INDIA MARKET ANALYSIS BY FIELD STRENGTH
    58. | 6.58 INDIA MARKET ANALYSIS BY TECHNOLOGY
    59. | 6.59 INDIA MARKET ANALYSIS BY TYPE
    60. | 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
    61. | 6.61 JAPAN MARKET ANALYSIS BY END USE
    62. | 6.62 JAPAN MARKET ANALYSIS BY FIELD STRENGTH
    63. | 6.63 JAPAN MARKET ANALYSIS BY TECHNOLOGY
    64. | 6.64 JAPAN MARKET ANALYSIS BY TYPE
    65. | 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    66. | 6.66 SOUTH KOREA MARKET ANALYSIS BY END USE
    67. | 6.67 SOUTH KOREA MARKET ANALYSIS BY FIELD STRENGTH
    68. | 6.68 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
    69. | 6.69 SOUTH KOREA MARKET ANALYSIS BY TYPE
    70. | 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
    71. | 6.71 MALAYSIA MARKET ANALYSIS BY END USE
    72. | 6.72 MALAYSIA MARKET ANALYSIS BY FIELD STRENGTH
    73. | 6.73 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
    74. | 6.74 MALAYSIA MARKET ANALYSIS BY TYPE
    75. | 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
    76. | 6.76 THAILAND MARKET ANALYSIS BY END USE
    77. | 6.77 THAILAND MARKET ANALYSIS BY FIELD STRENGTH
    78. | 6.78 THAILAND MARKET ANALYSIS BY TECHNOLOGY
    79. | 6.79 THAILAND MARKET ANALYSIS BY TYPE
    80. | 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
    81. | 6.81 INDONESIA MARKET ANALYSIS BY END USE
    82. | 6.82 INDONESIA MARKET ANALYSIS BY FIELD STRENGTH
    83. | 6.83 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
    84. | 6.84 INDONESIA MARKET ANALYSIS BY TYPE
    85. | 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
    86. | 6.86 REST OF APAC MARKET ANALYSIS BY END USE
    87. | 6.87 REST OF APAC MARKET ANALYSIS BY FIELD STRENGTH
    88. | 6.88 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
    89. | 6.89 REST OF APAC MARKET ANALYSIS BY TYPE
    90. | 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. | 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
    92. | 6.92 BRAZIL MARKET ANALYSIS BY END USE
    93. | 6.93 BRAZIL MARKET ANALYSIS BY FIELD STRENGTH
    94. | 6.94 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
    95. | 6.95 BRAZIL MARKET ANALYSIS BY TYPE
    96. | 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
    97. | 6.97 MEXICO MARKET ANALYSIS BY END USE
    98. | 6.98 MEXICO MARKET ANALYSIS BY FIELD STRENGTH
    99. | 6.99 MEXICO MARKET ANALYSIS BY TECHNOLOGY
    100. | 6.100 MEXICO MARKET ANALYSIS BY TYPE
    101. | 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
    102. | 6.102 ARGENTINA MARKET ANALYSIS BY END USE
    103. | 6.103 ARGENTINA MARKET ANALYSIS BY FIELD STRENGTH
    104. | 6.104 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
    105. | 6.105 ARGENTINA MARKET ANALYSIS BY TYPE
    106. | 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    107. | 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
    108. | 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY FIELD STRENGTH
    109. | 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
    110. | 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    111. | 6.111 MEA MARKET ANALYSIS
    112. | 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    113. | 6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE
    114. | 6.114 GCC COUNTRIES MARKET ANALYSIS BY FIELD STRENGTH
    115. | 6.115 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
    116. | 6.116 GCC COUNTRIES MARKET ANALYSIS BY TYPE
    117. | 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    118. | 6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE
    119. | 6.119 SOUTH AFRICA MARKET ANALYSIS BY FIELD STRENGTH
    120. | 6.120 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
    121. | 6.121 SOUTH AFRICA MARKET ANALYSIS BY TYPE
    122. | 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
    123. | 6.123 REST OF MEA MARKET ANALYSIS BY END USE
    124. | 6.124 REST OF MEA MARKET ANALYSIS BY FIELD STRENGTH
    125. | 6.125 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
    126. | 6.126 REST OF MEA MARKET ANALYSIS BY TYPE
    127. | 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. | 6.128 RESEARCH PROCESS OF MRFR
    129. | 6.129 DRO ANALYSIS OF HEALTHCARE
    130. | 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. | 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. | 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. | 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    134. | 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    135. | 6.135 HEALTHCARE, BY END USE, 2024 (% SHARE)
    136. | 6.136 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    137. | 6.137 HEALTHCARE, BY FIELD STRENGTH, 2024 (% SHARE)
    138. | 6.138 HEALTHCARE, BY FIELD STRENGTH, 2024 TO 2035 (USD Billion)
    139. | 6.139 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
    140. | 6.140 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    141. | 6.141 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    142. | 6.142 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
    143. | 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY END USE, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    8. | | 7.2.5 BY TYPE, 2025-2035 (USD Billion)
    9. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    10. | | 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
    11. | | 7.3.2 BY END USE, 2025-2035 (USD Billion)
    12. | | 7.3.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    13. | | 7.3.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    14. | | 7.3.5 BY TYPE, 2025-2035 (USD Billion)
    15. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    16. | | 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
    17. | | 7.4.2 BY END USE, 2025-2035 (USD Billion)
    18. | | 7.4.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    19. | | 7.4.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    20. | | 7.4.5 BY TYPE, 2025-2035 (USD Billion)
    21. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    22. | | 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
    23. | | 7.5.2 BY END USE, 2025-2035 (USD Billion)
    24. | | 7.5.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    25. | | 7.5.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    26. | | 7.5.5 BY TYPE, 2025-2035 (USD Billion)
    27. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    28. | | 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
    29. | | 7.6.2 BY END USE, 2025-2035 (USD Billion)
    30. | | 7.6.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    31. | | 7.6.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    32. | | 7.6.5 BY TYPE, 2025-2035 (USD Billion)
    33. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
    35. | | 7.7.2 BY END USE, 2025-2035 (USD Billion)
    36. | | 7.7.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    37. | | 7.7.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    38. | | 7.7.5 BY TYPE, 2025-2035 (USD Billion)
    39. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    40. | | 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
    41. | | 7.8.2 BY END USE, 2025-2035 (USD Billion)
    42. | | 7.8.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    43. | | 7.8.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    44. | | 7.8.5 BY TYPE, 2025-2035 (USD Billion)
    45. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    46. | | 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
    47. | | 7.9.2 BY END USE, 2025-2035 (USD Billion)
    48. | | 7.9.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    49. | | 7.9.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    50. | | 7.9.5 BY TYPE, 2025-2035 (USD Billion)
    51. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    52. | | 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
    53. | | 7.10.2 BY END USE, 2025-2035 (USD Billion)
    54. | | 7.10.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    55. | | 7.10.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    56. | | 7.10.5 BY TYPE, 2025-2035 (USD Billion)
    57. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    58. | | 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
    59. | | 7.11.2 BY END USE, 2025-2035 (USD Billion)
    60. | | 7.11.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    61. | | 7.11.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    62. | | 7.11.5 BY TYPE, 2025-2035 (USD Billion)
    63. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
    65. | | 7.12.2 BY END USE, 2025-2035 (USD Billion)
    66. | | 7.12.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    67. | | 7.12.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    68. | | 7.12.5 BY TYPE, 2025-2035 (USD Billion)
    69. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    70. | | 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
    71. | | 7.13.2 BY END USE, 2025-2035 (USD Billion)
    72. | | 7.13.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    73. | | 7.13.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    74. | | 7.13.5 BY TYPE, 2025-2035 (USD Billion)
    75. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    76. | | 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
    77. | | 7.14.2 BY END USE, 2025-2035 (USD Billion)
    78. | | 7.14.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    79. | | 7.14.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    80. | | 7.14.5 BY TYPE, 2025-2035 (USD Billion)
    81. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    82. | | 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
    83. | | 7.15.2 BY END USE, 2025-2035 (USD Billion)
    84. | | 7.15.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    85. | | 7.15.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    86. | | 7.15.5 BY TYPE, 2025-2035 (USD Billion)
    87. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    88. | | 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
    89. | | 7.16.2 BY END USE, 2025-2035 (USD Billion)
    90. | | 7.16.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    91. | | 7.16.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    92. | | 7.16.5 BY TYPE, 2025-2035 (USD Billion)
    93. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
    95. | | 7.17.2 BY END USE, 2025-2035 (USD Billion)
    96. | | 7.17.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    97. | | 7.17.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    98. | | 7.17.5 BY TYPE, 2025-2035 (USD Billion)
    99. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    100. | | 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
    101. | | 7.18.2 BY END USE, 2025-2035 (USD Billion)
    102. | | 7.18.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    103. | | 7.18.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    104. | | 7.18.5 BY TYPE, 2025-2035 (USD Billion)
    105. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    106. | | 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
    107. | | 7.19.2 BY END USE, 2025-2035 (USD Billion)
    108. | | 7.19.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    109. | | 7.19.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    110. | | 7.19.5 BY TYPE, 2025-2035 (USD Billion)
    111. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    112. | | 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
    113. | | 7.20.2 BY END USE, 2025-2035 (USD Billion)
    114. | | 7.20.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    115. | | 7.20.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    116. | | 7.20.5 BY TYPE, 2025-2035 (USD Billion)
    117. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    118. | | 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
    119. | | 7.21.2 BY END USE, 2025-2035 (USD Billion)
    120. | | 7.21.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    121. | | 7.21.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    122. | | 7.21.5 BY TYPE, 2025-2035 (USD Billion)
    123. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
    125. | | 7.22.2 BY END USE, 2025-2035 (USD Billion)
    126. | | 7.22.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    127. | | 7.22.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    128. | | 7.22.5 BY TYPE, 2025-2035 (USD Billion)
    129. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    130. | | 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
    131. | | 7.23.2 BY END USE, 2025-2035 (USD Billion)
    132. | | 7.23.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    133. | | 7.23.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    134. | | 7.23.5 BY TYPE, 2025-2035 (USD Billion)
    135. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    136. | | 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
    137. | | 7.24.2 BY END USE, 2025-2035 (USD Billion)
    138. | | 7.24.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    139. | | 7.24.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    140. | | 7.24.5 BY TYPE, 2025-2035 (USD Billion)
    141. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    142. | | 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
    143. | | 7.25.2 BY END USE, 2025-2035 (USD Billion)
    144. | | 7.25.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    145. | | 7.25.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    146. | | 7.25.5 BY TYPE, 2025-2035 (USD Billion)
    147. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    148. | | 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
    149. | | 7.26.2 BY END USE, 2025-2035 (USD Billion)
    150. | | 7.26.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    151. | | 7.26.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    152. | | 7.26.5 BY TYPE, 2025-2035 (USD Billion)
    153. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    154. | | 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
    155. | | 7.27.2 BY END USE, 2025-2035 (USD Billion)
    156. | | 7.27.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    157. | | 7.27.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    158. | | 7.27.5 BY TYPE, 2025-2035 (USD Billion)
    159. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    160. | | 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
    161. | | 7.28.2 BY END USE, 2025-2035 (USD Billion)
    162. | | 7.28.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    163. | | 7.28.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    164. | | 7.28.5 BY TYPE, 2025-2035 (USD Billion)
    165. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    166. | | 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
    167. | | 7.29.2 BY END USE, 2025-2035 (USD Billion)
    168. | | 7.29.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    169. | | 7.29.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    170. | | 7.29.5 BY TYPE, 2025-2035 (USD Billion)
    171. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    172. | | 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
    173. | | 7.30.2 BY END USE, 2025-2035 (USD Billion)
    174. | | 7.30.3 BY FIELD STRENGTH, 2025-2035 (USD Billion)
    175. | | 7.30.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    176. | | 7.30.5 BY TYPE, 2025-2035 (USD Billion)
    177. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    178. | | 7.31.1
    179. | 7.32 ACQUISITION/PARTNERSHIP
    180. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

  • Diagnostic Imaging
  • Functional Imaging
  • Spectroscopy
  • Cardiac Imaging

Healthcare By End Use (USD Billion, 2025-2035)

  • Hospitals
  • Diagnostic Imaging Centers
  • Research Institutions
  • Outpatient Facilities

Healthcare By Field Strength (USD Billion, 2025-2035)

  • Low Field
  • Mid Field
  • High Field
  • Ultra High Field

Healthcare By Technology (USD Billion, 2025-2035)

  • Closed MRI Systems
  • Open MRI Systems
  • Extremity MRI Systems
  • Hybrid MRI Systems

Healthcare By Type (USD Billion, 2025-2035)

  • Permanent Magnet MRI Systems
  • Superconducting MRI Systems
  • Resistive MRI Systems
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions
%>